147 results on '"Shin, Jong Hee"'
Search Results
2. Anti-Myeloma Effect of Compound K and Rh2 in a Multiple Myeloma Xenograft Model
3. Derivative Compounds of Chromanone As Candidates for Multiple Myeloma-Targeted Anticancer Drugs
4. A Clinical Laboratory-Oriented Targeted RNA-Seq System Accurately and Efficiently Detected Various Fusion Gene Mutations in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia
5. Development of a Targeted NGS Panel for Hematologic Malignancies According to Who/ICC 2022 Guidelines
6. Diagnostic Validation of a Clinical Laboratory-Oriented Targeted RNA Sequencing System As a Comprehensive Assay for Hematologic Malignancies
7. RNA Sequencing Based Whole Transcriptome Analysis Detected Precisely All Fusion Transcripts in Leukemias
8. Expression Status of Prohibitin Gene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics
9. Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia
10. No Mutations of SF3B1, U2AF1, and SRSF2 spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma
11. Overexpression of Phospholipase C Beta 2 Is Associated with Favorable Prognosis in Normal Karyotype Acute Myeloid Leukemia
12. Altered Cellular Responses As Biomarkers for Fluoranthene Exposure to the Bone Marrow-Mesenchymal Stem Cells: Implications for Stem Cell-Based in Vitro Models That Help Determine the Associated Hematotoxicity
13. Prevalence and Clinical Impacts Of SETBP1 Mutation In East Asian Patients With MDS/MPN
14. Clinical Significance Of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome
15. Serum Level Of Parathyroid Hormone Is Associated With Risk Factors and Clinical Outcomes In Multiple Myeloma
16. Profiling Of Polycyclic Aromatic Hydrocarbons-Induced Genotoxicity In Peripheral Blood Stem Cells and Bone Marrow Mesenchymal Stem Cells
17. Development Of Novel Alkylating Chemotherapeutics, Phenyl-Chloroethyl Urea Family, Targeting Mitochondrial Prohibitin For Selective Killing Of Leukemic Cells
18. No Recurrent Mutation of SF3B1, U2AF1 and SRSF2 Spliceosomal Gene in Multiple Myeloma but Polymorphisms of These Genes Are Associated with the Prediction of Worse Prognosis
19. Protein Profiling of Hematopoietic Progenitor Cells and Leukemia Cells Identifies Novel Biomarkers Associated with Exposure of Polycyclic Aromatic Hydrocarbons
20. Low Mutation Rate and No Significant Prognostic Implication of SF3B1, U2AF1 and SRSF2 Genes in Myelodysplastic Syndrome without Harboring Ring Sideroblast
21. Mitochondrial DNA Minisatellites Showed Higher Informativeness and Sensitivity Than the Nuclear DNA Markers for the Quantitative Determination of Chimerism After Allogeneic Stem Cell Transplantation,
22. Distinctive Spectra of Cytogenetic Alterations in Over Five Hundred East Asian Patients with Acute Leukemia
23. Biomarker for Benzopyrene Exposure Is Mitochondrial Mass and Mitochondrial DNA Copy in Blood Cells and Hematopoietic Tissues
24. Metformin Selectively Suppressed the Proliferation of AML Stem Cells through Increased Phosphorylation of AMP-Activated Protein Kinase
25. Distinctive Hematological Abnormalities and GATA1 Mutation Spectra In East Asian Neonates and Children with Down Syndrome
26. The Spectra of Chromosomal Aberrations In Acute Leukemia and Implications for the Development of Optimal Profiles of Leukemic Fusion Genes In Multiplex RT-PCR System.
27. Prohibitin Serves as a Novel Target Mitochondrial Protein of Phenyl-Chloroethyl Ureas Involved In Their Antiproliferative Effect on Multiple Myeloma Cells
28. AML FAB Subtypes Shows Different Proportion of Leukemia Initiating Cell Which Has Lower Single Cell Dividing Property.
29. Increased Mitochondrial Mass and Mitochondrial DNA Copy Number Are Biomarkers for Benzene Exposure in Hematopoietic Tissue and Leukemia Cells.
30. The Prohibitin 3′ Untranslated Region Polymorphisms Are Associated with AML Susceptibility.
31. Profound Length Heteroplasmic Alterations in Mitochondrial DNA Control Region From Primary AML Cells: Implication of Impaired Mitochondrial Replication and Demonstration of ‘vicious cycle’ Hypothesis.
32. SET-NUP214 Fusion Gene at Chromosome 9q34 Contributed to the Development of Not Only T-ALL, but Also Primary and Secondary AML.
33. Direct Confirmation of Quiescent Property of AML Stem Cells by Showing Markedly Decreased Plating Efficiency in Single Leukemic Stem Cell Culture
34. Discovery of a New Molecular Marker, Prohibitin, and Development of Candidates for New Chemotherapeutic Agents Targeting Prohibitin in Primary AML Cells.
35. Identification of Differentially Expressed Proteins from the Mitochondria Enriched Cytoplasmic Fractions in Primary AML Cells.
36. Allelic Expression Imbalance of JAK2 V617F Mutant Contributes to Phenotypic Variation in BCR-ABL Negative Chronic Myeloproliferative Disorders.
37. Dynamic Mitochondrial Responses to Oxidative Stress in Primary AML Cells Involve Structural Damage and Repair Activity.
38. Impaired Activity of Mitochondrial Respiratory Chain Enzyme Complexes and Mitochondrial Genomic Aberrations in Leukemia Cells from Patients with Acute Myeloid Leukemia.
39. Frequency of the JAK2 Mutation and Its Usefulness as a Marker for Treatment Response and Disease Progression in Korean Patients with Chronic Myeloproliferative Disorders.
40. Dispermic Chimerism in a Blood Donor with Apparent B3 Blood Group and Mosaic 47, XYY Syndrome.
41. Mitochondrial Genome Instability in AML Is Associated with Reduction in the Mitochondrial Replication.
42. Mitochondrial DNA Microsatellites as New Markers for the Quantitative Determination of Hematopoietic Chimerism after Allogeneic Stem Cell Transplantation.
43. Biological Significance and Profile of Length Heteroplasmy in the Hypervariable Segments of the Human Mitochondrial DNA Control Regions from Blood Cells.
44. Expression Status of ProhibitinGene Predicts the Prognosis of Acute Myeloid Leukemia with Normal Cytogenetics
45. No Mutations of SF3B1, U2AF1, and SRSF2spliceosomal Gene but Polymorphisms Associated with the Worse Prognosis in Multiple Myeloma
46. Altered Cellular Responses As Biomarkers for Fluoranthene Exposure to the Bone Marrow-Mesenchymal Stem Cells: Implications for Stem Cell-Based in VitroModels That Help Determine the Associated Hematotoxicity
47. Clinical Significance Of SF3B1, U2AF1and SRSF2Spliceosomal Gene Mutations For The Treatment Of Hypomethylating Agents In Myelodysplastic Syndrome
48. Prevalence and Clinical Impacts Of SETBP1Mutation In East Asian Patients With MDS/MPN
49. No Recurrent Mutation of SF3B1, U2AF1and SRSF2Spliceosomal Gene in Multiple Myeloma but Polymorphisms of These Genes Are Associated with the Prediction of Worse Prognosis
50. Low Mutation Rate and No Significant Prognostic Implication of SF3B1, U2AF1and SRSF2Genes in Myelodysplastic Syndrome without Harboring Ring Sideroblast
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.